prostate cancer

Research in Review

Expectant Management for Prostate Cancer Underutilized at Community Centers

07/15/2016

JCP Editors

A retrospective analysis of hospital trends has shown that the likelihood of receiving expectant management for low-risk prostate cancer was significantly lower in men evaluated at community centers compared with...

A...

07/15/2016

Journal of Clinical Pathways

Research in Review

Inherited Genes Highly Prevalent in Metastatic Prostate Cancer

07/12/2016

JCP Editors

Findings from a study recently published in the New England Journal of Medicine suggest that men with advanced prostate cancer may want to consider being tested for inherited gene mutations in order to help guide...

...

07/12/2016

Journal of Clinical Pathways

Prostate Cancer Treatment Associated With More Adverse Events

06/10/2016

JCP Editors

Patients with metastatic castrate resistant prostate cancer treated with enzalutamide (ENZ) may be more likely to experience central nervous system adverse events and fatigue than those who receive a combination of...

...

06/10/2016

Journal of Clinical Pathways

Research in Review

Stereotactic Body Radiation Therapy Results in Almost 100% Cure Rate For Patients With Prostate Cancer

04/22/2016

JCP Editors

A recent study showed a 98.6% cure rate at 5 years with stereotactic body radiation therapy (SBRT) in patients with low- or intermediate-risk prostate cancer. Current forms of radiation for prostate cancer are...

A...

04/22/2016

Journal of Clinical Pathways

Research in Review

Active Surveillance Poses Risk of Metastasis for Certain Patients With Prostate Cancer

04/19/2016

JCP Editors

A percentage of patients on active surveillance for clinically insignificant prostate cancer may be at risk of developing metastatic disease in the long term. A study published in The Journal of Urology has reported...

A...

04/19/2016

Journal of Clinical Pathways

Research in Review

Patients With Prostate Cancer Do Not Benefit From Higher Doses of Radiotherapy

04/06/2016

JCP Editors

While advances in technology have allowed physicians to administer higher doses of radiation to treat prostate cancer, results from a recent study have revealed that escalating dose may not help patients in the long...

While...

04/06/2016

Journal of Clinical Pathways

Research in Review

Hypofractionation Leads to Greater Toxicity in Patients with Prostate Cancer

03/29/2016

JCP Editors

A new study has failed to demonstrate hypofractionated radiotherapy as a non-inferior option to fractionated radiotherapy for patients with intermediate- or high-risk prostate cancer. In patients with genitourinary...

A new...

03/29/2016

Journal of Clinical Pathways

Patients With Prostate Cancer Report Better QoL With Active Surveillance

03/16/2016

JCP Editors

Active surveillance (AS) for patients with low-risk prostate cancer can provide similar quality of life to that of men living without cancer, according to a study presented at the European Association of Urology...

Active...

03/16/2016

Journal of Clinical Pathways

Research in Review

Use of MRI Influences Physician Decision-Making in Prostate Cancer

03/10/2016

JCP Editors

A study of prostate cancer has found that MRI (magnetic resource imaging) evaluations can influence clinical decision-making for both physicians and patients, though whether those decisions result in superior...

A...

03/10/2016

Journal of Clinical Pathways

Research in Review

Stereotactic Body Radiation More Cost-Effective for Treating Prostate Cancer Than Standard Therapy

03/08/2016

JCP Editors

Stereotactic body radiotherapy (SBRT) with a robotic system is currently more cost-effective than standard regimens as well as SBRT delivered with other systems for the treatment of prostate cancer, according to a...

...

03/08/2016

Journal of Clinical Pathways